Stonegate Capital Partners is a leading advisory firm founded in 1972. We specialize in capital markets advisory with a focus on institutional investor outreach for publicly traded companies.
Corporate Access Events
Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (Nasdaq:BPTH)
DALLAS, TX -- September 30, 2022 -- Bio-Path Holdings, Inc. (Nasdaq:BPTH): The full report can be accessed by clicking on the following link: https://stonegateinc.com/reports/BPTH_Q2FY22.pdf COMPANY DESCRIPTION Bio-Path Holdings, Inc. (Bio-Path) is a clinical stage biotechnol...
Battling Blindness: Virtual Investor Event on Treatments for Retinitis Pigmentosa to Be Held October 19; Panelists include Kiora Pharmaceuticals, Foundation Fighting Blindness, and Retinal Surgeon Christine Kay, M.D.
Dallas, TX - September 28, 2022 - Stonegate Healthcare will host a virtual investor event with ophthalmology experts to discuss Retinitis Pigmentosa (RP) and the pipeline of products in development. Participants will include Christine Kay, M.D., Vitreoretinal surgeon and IRD s...
Stonegate Capital Partners Updates Coverage on Steppe Gold Ltd. (TSX:STGO)
DALLAS, TX -- September 12, 2022 -- Steppe Gold Ltd. (TSX:STGO): The full report can be accessed by clicking on the following link: https://stonegateinc.com/reports/STGO_Q2FY22.pdf COMPANY DESCRIPTION Steppe Gold Ltd. is a precious metals exploration and production Company wi...